Moral Injury (MI), as a multidimensional syndrome with a range of symptoms, is of increasing interest and concern both nationally and internationally. Unfortunately, the field of MI is still in a somewhat immature and developmental state (Litz, 2025; Litz & Walker, 2025). This presents many challenges for how it is considered from a governmental, organisational, and clinical perspective. These challenges include the nosology of the diagnosis itself; to what extent exposure or potential exposure during military service leads to the presence of symptoms; how it has been included in the DSM-5-TR as a Z-code in the categorical model of the DSM-V-TR and what that actually means (Mattson, et al, 2025); as well as what treatments best suit the veteran population (Litz, 2025). This presentation will look at these issues from both a policy and clinical perspective, noting the need for government agencies such as the Department of Veterans’ Affairs to manage a wide range of both policy and implementation perspectives in regard to MI.